$IONS·4

ISIS PHARMACEUTICALS INC · May 26, 7:39 PM ET

ISIS PHARMACEUTICALS INC 4

4 · ISIS PHARMACEUTICALS INC · Filed May 26, 2005

Insider Transaction Report

Form 4
Period: 2005-05-25
Wedel Mark K
VP & Chief Medical Officer
Transactions
  • Award

    Common Stock

    2005-05-25+10,00010,000 total
    Exercise: $3.94From: 2009-05-25Exp: 2012-05-24Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]Grant of 5-25-05 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option will vest and become exercisable on 5-25-06. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 2,500 shares per year. The option is exercisable as to 0 shares on 5-25-05.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT